Quality of life and peripheral arterial disease: Perspectives for the future

Drugs

Volumn 56, Issue SUPPL. 3, 1998, Pages 49-58

  Priollet, P ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; IFENPRODIL TARTRATE;

ARTERY DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; DIABETES MELLITUS; EARLY DIAGNOSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; MORBIDITY; MORTALITY; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RISK FACTOR; SCREENING; SYMPTOMATOLOGY; TREATMENT PLANNING; WALKING; BLOOD FLOW; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ARTERIAL OCCLUSIVE DISEASES; HUMANS; REGIONAL BLOOD FLOW;

EID: 0032246697     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199856003-00006     Document Type: Review

References (29)

1. Baumgarten I, Pieczeck A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischaemia. Circulation 1998; 97: 1114-23
2. European Working Group on critical leg ischemia. Eur J Vasc Surg 1992; 6 Suppl. A: S1-32
3. Criqui MH, Fronek A, Barret-Connor R, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-5
4. Priollet P, Chalon S. Artérites athéroscléreuses des membres inférieurs. Des symptômes au traitement médical. Paris: Elsevier, 1995
5. Baron JF, Mundler O, Bertrand M, et al. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to access cardiac risk before abdominal aortic surgery. N Engl J Med 1994; 330: 663-9
6. Janzon L, Bergqvist D, Boberg J, et al. Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine: results from STIMS, the Swedish Ticlopidine Multicenter Study. J Intern Med 1990; 227 (5): 301-8
7. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol 1992; 45 (5): 529-42
8. Artériopathie des membres inférieurs. Dépistage et risque cardiovasculaire. Paris: Les éditions INSERM, 1994
9. Priollet P, Lazareth I, Manière-Constantin D, et al. Renal artery stenosis and peripheral vascular disease. Lancet 1990; 336: 879
10. Taylor DC, Kettler MD, Moneta CL, et al. Duplex ultrasound scanning in the diagnosis of renal artery stenosis: a prospective evaluation. J Vasc Surg 1988; 7: 363-9
11. Quick CRG, Cotton LT. The measured effect of stopping smoking on intermittent claudication. Br J Surg 1982; 62 Suppl.: S24-29
12. Jonason T, Ringqvist I. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication. Acta Med Scand 1985; 218 (2): 27-33
13. Myers KA, King RB, Scott DR The effect of smoking on the late patency of arterial reconstructions in the legs. Br J Surg 1978; 65: 267-71
14. Provan JL, Sojka SG, Murnaghan JJ. The effect of cigarette smoking on the long term success rates of aortofemoral and femoro-popliteal reconstructions. Surg Gynecol Obstet 1987; 165 (1): 49-52
15. Jonason T, Bergström R. Cessation of smoking in patients with intermittent claudication. Acta Med Scand 1987; 221: 253-60
16. Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA 1994; 271 (24): 1940-7
17. Cazaubon M, Blanchemaison P. Règles de prévention en pathologie vasculaire périphérique. In: Encycl Med Chir. Angéiologie 19-3680. Paris: Elsevier, 1997
18. Priollet P. Prise en charge de la nécrose tissulaire du pied chez le diabétique. In: Journées de diabétologie. Paris: Flammarion Médecine-Sciences, 1990: 117-27
19. Emmerich J. Traitement médical de l'artérite. In: Encycl Med Chir. Angéiologie 19-3620. Paris: Eisevier, 1997
20. Fowkes FGR, Housley E, Riemersma RA, et al. Smoking, lipids, glucose intolerance and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992; 135 (4): 331-40
21. Radach K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med 1991; 151: 1769-76
22. Boissel JP, Peyrieux JC, Destors JM. Is it possible to reduce the risk of cardiovascular events in subjects suffering from intermittent claudication of the lower Jimbs? Throm Haemost 1989; 62: 681-5
23. CARRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39
24. The epic investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-61
25. Weitz JI, Byrne IJ, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996; 94 (11): 3026-49
26. Agence Nationale pour le Développement de l'Evaluation Médicale (ANDEM). Prescription des vasoactifs dans le traitement de l'artériopathie oblitérante des membres inférieurs. In: Recommandations et références médicales. Chapter XI, Tome 2. Paris: ANDEM, 1994: 243-62
27. Barletta G, Perna S, Sabba C, et al. Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. Vase Med 1996; 1: 3-7
28. Marquis P, Fayol C, McCarthy C, et al. Mesure de la qualité de vie dans la claudication intermittente: validation clinique d'un questionnaire [measurement of quality of life in intermittent claudication: clinical validation of a questionnaire]. Presse Med 1994; 23 (28): 1288-92
29. Marquis P, Lecasble M, Passa Ph. Qualité de vie de patients souffrant d'AOMI traités par le tartrate d'ifenprodil: résultats de l'étude ARTEMIS. Drugs 1998; 56 Suppl. 3: 37-48